Declining trend of HTLV-1 among organ/tissue donors in Iran
Author Information
Author(s): Letafati Arash, Mozhgani Sayed Hamidreza, Norouzi Mehdi, Aboofazeli Amir, Taghiabadi Zahra, Zafarian Negar, Seyedi Saba, Jaberi Elnaz Mohammad, Poursaleh Sedigheh, Karami Maryam, Sarrafzadeh Sheida, Sadeghi Ahmadreza
Primary Institution: Tehran University of Medical Sciences
Hypothesis
What is the prevalence of HTLV-1 in potential organ/tissue donors in Iran between 2014 and 2021?
Conclusion
The study found a significant decline in HTLV-1 prevalence among organ/tissue donors in Iran from 2014 to 2021.
Supporting Evidence
- 111 out of 3,814 donors were positive for HTLV-1 (3%).
- The rate of positive tests between 2014 and 2017 was 6%, significantly higher than the 0.5% from 2017 to 2021.
- Females had a higher prevalence of HTLV-1 infection (4%) compared to males (2%).
- Brain death donors had a significantly lower likelihood of HTLV-1 infection (0.2%) compared to circulatory death donors (4%).
Takeaway
The study looked at how many organ donors in Iran had a virus called HTLV-1, and it found that fewer people had it over the years.
Methodology
The study used ELISA for initial screening and PCR for confirmation of HTLV-1 infection in potential organ/tissue donors.
Potential Biases
Potential bias due to the focus on deceased donors and the exclusion of living donors.
Limitations
The study focused only on deceased donors, which may limit the generalizability of the findings.
Participant Demographics
The study included 2,577 male and 1,237 female potential organ/tissue donors with a median age of 32.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website